Oral thrush is a fungal infection caused by accumulation of species Candidas on the mucus membrane of the mouth.
Oral Thrush Treatment Market: Introduction
- Oral thrush is a fungal infection caused by accumulation of species Candidas on the mucus membrane of the mouth
- Candida albicans infects men and women of all age groups. It is the normal inhabitant of oral microbiota in about 50% of the global population. Candida albicans is normally present in the mouth, but sometimes it can overgrow and become pathogenic to the host tissue.
Read Report Overview - https://www.transparencymarketresearch.com/oral-thrush-treatment-market.html
- Oral thrush usually causes the development of a creamy white lesion on the tongue or inner cheeks. In some cases, it could spread to the gums, tonsils, and/or roof of the oral cavity. In severe cases such as cancer or HIV/AIDS, lesions get worse and spread downward into the esophagus.
- Diagnosis of oral thrush depends on the location. If the thrush is limited to the mouth, then it can be diagnosed by microscopic examination and blood tests. If oral thrush has spread into the esophagus, then it can be diagnosed with the help of biopsy, endoscopic examination, and/or physical examination.
- Moreover, oral thrush can be treated with topical anti-infectives such as gentian violet and antifungals such as fluconazole and clotrimazole
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43700
Key Drivers and Restrains of Global Oral Thrush Treatment Market
- Increase in incidence of candidiasis infections and rise in awareness about fungal infections are projected to drive the global oral thrush treatment market during the forecast period
- According to the Centers for Disease Control and Prevention (CDC), during 2013–2017, the average incidence of candidemia was 9 per 100,000 people in the U.S. However, this number varies substantially by geographic location and patient population. An estimated 25,000 cases of candidemia are recorded in the country each year.
- Rise in hygiene awareness in developing countries and popularity of over-the-counter antifungal drugs are anticipated to propel the global oral thrush treatment market in the near future
- However, availability of alternative treatments such digestive health probiotics and occurrence of severe adverse drug reactions are expected to restrain the global oral thrush treatment market
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43700
North America to Lead Global Oral Thrush Treatment Market
- In terms of region, the global oral thrush treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is likely to account for major share of the global market due to rise in usage of these medications and high health care expenditure. Additionally, rapid uptake of new products, concentration of major players in the U.S., and larger use oral hygiene products are projected to augment the market in the region.
- Europe is anticipated to be a significant market for oral thrush treatment during the forecast period, due to rise in prevalence of fungal infections and increase in awareness about new treatment options
- The oral thrush treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Growth of the market in the region can be attributed to rise in awareness about personal hygiene and access to better health care facilities.
- The market in Latin America and Middle East & Africa is likely to grow at a steady pace due to the presence of rapidly developing economies and lifestyle changes of the population in these regions
Pre Book Oral Thrush Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=43700<ype=S
Key Players Operating in Global Oral Thrush Treatment Market
Key players operating in the global oral thrush treatment market are:
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Pfizer, Inc.
- Cipla Ltd.
- Janssen Pharmaceuticals (Johnson & Johnson)
- Gilead Sciences, Inc.
- Perrigo Company plc
- AdvaCare Pharma
- Mylan N.V. (Mylan N.V.)
- Abbott
- CHEPLAPHARM Arzneimittel GmbH
- Other prominent players
Browse more Reports by Transparency Market Research:
Cancer Cachexia Market: The global market for cancer cachexia market is currently in the budding stage. On the grounds of promising clinical pipeline and imminent regulatory approvals, this market is expected to witness exceptional rise over the coming years.
Cardiovascular Drugs Market: The global cardiovascular drugs market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/